Medable delivers a cloud-based clinical trial management platform designed for decentralized and hybrid research models. Founded in 2012 by Fernando Waigandt, James Sas, Michelle Longmire, Perry Robinson, and Tim Smith, the company is headquartered in Palo Alto, California, United States, and employs 376 people as of December 2022.
Its platform supports patient screening, tele-consent, remote monitoring, and data collection for Sponsors, CROs, and research sites globally (30+ countries, 26 languages) and is used across biotech and pharmaceutical sectors to make trials faster and more patient-centric.
What Is Medable and What Does It Do?
Founded in 2012, Medable is based in Palo Alto, United States. With a team of around 376 employees, it offers a digital platform that enables patient-centric and decentralized clinical trials. Through features like remote patient monitoring, tele-consent management, eCOA (electronic clinical outcome assessments), and mobile apps, Medable connects patients, trial sites, and data streams to streamline trial operations.
The platform is globally compliant, helping sponsors accelerate study start-up, enhance retention, optimize data quality, and reduce costs across diverse therapeutic areas.
How Much Funding Has Medable Raised?
- Series C
- Amount Raised: $91M
- Date: November 2020
- Lead Investors: Sapphire Ventures (and follow-on)
- Motivation: To accelerate digital and decentralized trial capabilities during the COVID-19 pandemic.
- Series C (Additional)
- Amount Raised: $78M
- Date: April 2021
- Lead Investors: Sapphire Ventures
- Motivation: To scale operations and expand product offerings globally.
- Series D
- Amount Raised: $304M
- Date: October 2021
- Lead Investors: Blackstone Growth, GSR Ventures, Tiger Global
- Motivation: To invest in remote-patient technologies, expand global operations, and deepen its SaaS platform.
Total Funding Raised: $521 Million
Current Valuation: $2.1 billion (as of Oct 2021)
Latest Funding Date: October 2021
Key Investors
- Sapphire Ventures
- Details: Growth-stage venture firm partnering with visionary tech companies.
- Investment Focus Areas: Technology companies, cloud, life sciences.
- Notable Investments: 23andMe, Box, Medable.
- Tiger Global Management
- Details: Global investment firm focused on internet and software companies.
- Investment Focus Areas: Software, fintech, healthtech.
- Notable Investments: Facebook, LinkedIn, Spotify, Medable.
- Blackstone Growth
- Details: The growth-equity arm of Blackstone, a major global investment firm.
- Investment Focus Areas: Private Equity, Life Sciences, and Technology.
- Notable Investments: Bumble, Oatly, Medable.
- GSR Ventures
- Details: Venture capital firm with a strong presence in digital health and technology.
- Investment Focus Areas: Early-stage technology and health tech.
- Notable Investments: Medable, many digital-health startups.
Where Is Medable’s Headquarters?
Medable is headquartered in Palo Alto, California, United States, a core hub for life-science innovation, digital health, and startup ecosystems. This location provides strategic access to leading biotech firms, research institutions, investor networks, and talent in digital health and clinical trial technology.
What’s Next for Medable?
Medable is targeting the growing global market for decentralized clinical trials, projected to reach $11.5 billion by 2028. With its 2024 momentum showing strong growth (e.g., 80% revenue growth for portfolio-level eCOA), the company focuses on scaling remote patient engagement, AI-driven analytics, and real-time trial monitoring worldwide.
Get Investor & Funding Insights with TexAu
TexAu helps sales and business teams uncover detailed fundraising information on companies like Medable. Use the platform to research investors, track funding rounds, and gather actionable insights to strengthen prospecting and business strategy.
Sign Up for Free on TexAu and start uncovering detailed funding insights that give your business a competitive edge.
